News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Artimplant Three - Month Report 2012
May 3, 2012
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
VÄSTRA FRÖLUNDA, Sweden--(BUSINESS WIRE)--Regulatory News: Net revenue amounted to SEK 6.8 million (5.4), an increase of 27 percentage points.The net loss totaled SEK 2.3 million (3.9). Earnings per stock unit amounted to SEK -0.01 (-0.03).
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
Layoff Tracker
Intercept Fires 146 After Pulling Liver Disease Drug
December 18, 2025
·
97 min read
·
BioSpace Editorial Staff
Layoffs
Voyager Throws 30 Staff Overboard After Novartis Sinks Two Programs
December 18, 2025
·
2 min read
·
Tristan Manalac
Startups
Addition Debuts With $100M to Advance One-Time Therapies for Rare, Chronic Diseases
December 17, 2025
·
1 min read
·
Tristan Manalac
Vaccines
Pfizer CEO Blasts HHS’ Anti-Vaccine Policies as Revenue Outlook Dims
December 16, 2025
·
3 min read
·
Annalee Armstrong